# US 2019/0309170 A1 · (dis)symmetric azomethine-type direct dye comprising at least one pyrazolopyridine unit, process for dyeing keratin fibers using this dye

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0309170 A1
- Document ID: US20190309170A1
- Status: Published application
- Kind: A1
- Application number: 16/309,296
- Filed: 2017-06-21
- Published: 2019-10-10
- Earliest claimed: 2016-06-23
- Assignees: L'oreal
- Applicants: L'oreal
- Inventors: Stéphane SABELLE; Stéphane BLAIS; Aziz FADLI
- Web page: https://patentgrep.com/patent/US20190309170A1

## CPC

- C09B 55/003: {with the -C=N- group attached to an heteroring}
- A61K 8/494: {with more than one nitrogen as the only hetero atom}
- A61K 8/4946: {Imidazoles or their condensed derivatives, e.g. benzimidazoles}
- A61Q 5/10: Preparations for permanently dyeing the hair
- C07D 471/04: Ortho-condensed systems
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C09B 53/02: Indamines; Indophenols
- A61K 2800/432: Direct dyes
- A61K 2800/87: Application Devices; Containers; Packaging
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The subject of the present invention is symmetric or dissymetric azomethine direct dyes comprising at least one pyrazolopyridine unit of formula (I), a composition comprising said dyes, a process for treating keratin fibers using said dyes, a process for preparing these compounds, synthesis intermediates and a kit. In which formula (I) X, Y1, Y2, Z1, and R1 to R5 are as defined in the description.

## Claims

### Claim at position 1

1-19. (canceled)

### Claim 20

A compound chosen from azomethine dyes comprising at least one pyrazolopyridine unit of formula (I), a leuco form, an optical isomer, a geometrical isomer, a tautomers thereof, an organic or mineral acid or base addition salt thereof, a solvate thereof, or a hydrate thereof:
in which formula (I):
Y1 and Y2, which may be identical or different, represent a nitrogen atom or a group C(R) with R representing a hydrogen atom or a (C1-C6)alkyl group;
Z1 represents an oxygen atom or a group —N(R6)—; when Z1 represents —N(R6)—, then R1 and R6 optionally form, together with the nitrogen atom to which they are attached, an optionally substituted, optionally cationic, 5- to 8-membered, saturated, unsaturated or aromatic heterocycle;
R1 and R6, which may be identical or different, represent:
a hydrogen atom;
a C1-C10 alkyl radical optionally interrupted with one or more non-adjacent heteroatoms, and/or optionally substituted;
an optionally substituted, 5- to 8-membered, cationic or non-cationic, saturated, unsaturated or aromatic (hetero)cyclic radical;
in particular R1 represents a (poly)hydroxy(C1-C6 alkyl) group;
R2, R3, R4, and R5, which may be identical or different, each independently represent:
a hydrogen atom;
an optionally substituted C1-C6 alkyl radical;
a group chosen from —NH2, —N(H)R10, —N(R11)R12, OH and/or —OR9, with R9 and R10 representing an optionally substituted, linear or branched C1-C6 alkyl, R11 and R12, which may be identical or different, representing an optionally substituted, linear or branched C1-C6 alkyl, it being possible for R11 and R12 to form, together with the nitrogen atom to which they are attached, a saturated, unsaturated or aromatic 5- to 8-membered heterocycle optionally containing one or more other heteroatoms or groups chosen from N, O, S, S(O)2 and C(O), the heterocycle being optionally substituted;
a halide and/or
R2, R3, R4, and R5 form, in pairs, with adjacent radicals, an optionally substituted, saturated or unsaturated (hetero)cycle;
X represents an optionally substituted aryl or optionally substituted heteroaryl radical;
wherein
when the compounds of formula (I) are cationic, then their electro-neutrality is provided by one or more cosmetically acceptable anions which may be identical or different; and
when Y1 represents NH and Y2 represents a CH group, then X represents a group other than a pyrazolo[1,5-a]pyridin-3-yl group which is optionally substituted.

### Claim 21 (depends on 20)

The compound of claim 20, wherein Y1 represents N and Y2 represents C(R)

### Claim 22 (depends on 20)

The compound of claim 20, wherein Y1 and Y2 represent a group C(R).

### Claim 23 (depends on 20)

The compound of claim 20, wherein X represents a group chosen from those of formula (II) or of formula (III):
in which formulae (II) and (III):
corresponds to the point of anchorage of the group (II) or (III) to the rest of the molecule;
Ar represents an aryl group optionally substituted with one or more radicals R8, which may be identical or different, R8 representing an atom or group chosen from:
-halogen;
—OR′14;
—NR14R15;
C1-C6 alkyl optionally substituted with one or more atoms or groups, which may be identical or different, chosen from i) hydroxyls, ii) amino, iii) (C1-C6)alkylamino, iv) di(C1-C6)alkylamino, v) halogen, vi) (C1-C6)alkylimidazolyl, v) tri(C1-C6)alkylammonium An−, vi) (C1-C6)alkylimidazolium An−, vii) (C1-C6)alkylpyridinium An−, viii) (C1-C6)alkylpiperidinium An−;
carboxyl (—C(O)—OH);
carboxamide (—C(O)—NRaRb) with Ra and Rb, which may be identical or different, representing a hydrogen atom or a (C1-C4)alkyl group; and
R9 represents:
a radical —OR′6; or
a radical —NR′6R′7;
when R9 represents —NR′6R′7 then R′6 and R′7 can form, together with the nitrogen atom to which they are attached, an optionally substituted, optionally cationic, 5- to 8-membered, saturated, unsaturated or aromatic heterocycle;
R′6 and R′7, which may be identical or different, represent:
a hydrogen atom;
a C1-C10 alkyl radical optionally interrupted with one or more non-adjacent heteroatoms, and/or optionally substituted with one or more groups chosen from i) hydroxyl, ii) optionally substituted, 5- to 8-membered, cationic or non-cationic, saturated, unsaturated or aromatic (hetero)cycle, iii) —N(R′)R″, iv) —N+R′R″R′″ with R′, R″ and R″ each independently representing a C1-C6 alkyl group;
an optionally substituted, 5- to 8-membered, cationic or non-cationic, saturated, unsaturated or aromatic (hetero)cyclic radical;
R10, R11, R12 and R13, which may be identical or different, represent:
a hydrogen atom;
an optionally substituted C1-C4 alkyl radical;
a group chosen from —NH2, —N(H)R16, —N(R17)R18, OH and —OR19, with R16 and R19 independently representing an optionally substituted, linear or branched C1-C6 alkyl, R17 and R18, which may be identical or different, representing an optionally substituted, linear or branched C1-C6 alkyl, optionally R17 and R18 form, together with the nitrogen atom to which they are attached, a saturated, unsaturated or aromatic 5- to 8-membered heterocycle optionally containing one or more other heteroatoms or groups chosen from N, O, S, S(O)2 and/or C(O), the heterocycle being optionally substituted; and/or
R10, R11, R12, and R13 form, in pairs, with adjacent radicals, an optionally substituted, saturated or unsaturated (hetero)cycle;
R14 and R15, which may be identical or different, represent an atom or group chosen from:
a hydrogen atom;
a linear or branched C1-C6 alkyl radical optionally substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino, (C1-C6)alkylimidazole, mono/di/tri(C1-C6)alkylammonium, An−, (C1-C6)alkylimidazolium An−, (C1-C6)alkylpyridinium An−; (C1-C6)alkylpiperidinium, An−; or
R14 and R15 form, together with the nitrogen to which they are attached, a cationic or non-cationic 4- to 7-membered heterocycle which may also contain one or more heteroatoms such as nitrogen, oxygen and/or sulfur, said heterocycle possibly being substituted with one or more radicals, which may be identical or different, chosen from hydroxyl, amino, (di)(C1-C6)alkylamino, C1-C6 alkoxy, mono/di/tri(C1-C6)alkylammonium, An−; (C1-C6)alkylimidazolium, An−; (C1-C6)alkylpyridinium, An−; or C1-C6 alkyl;
R′14 represents an atom or group chosen from:
hydrogen;
linear or branched C1-C6 alkyl which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyl, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino, (C1-C6)alkylimidazole, mono/di/tri(C1-C6)alkylammonium An−, (C1-C6)alkylimidazolium An−, (C1-C6)alkylpyridinium An−, (C1-C6)alkylpiperidinium An−;
wherein when the compounds of formula (I) are cationic, then their electro-neutrality is provided by one or more anionic counterions An−; and when Y1 represents NH and Y2 represents a CH group, then X represents a radical (II).

### Claim 24 (depends on 20)

The compound of claim 20, wherein X represents an aryl group of formula (II) with:
Ar represents a substituted aryl group, of which at least one of the substituents R5 represents a radical —OR′14 and/or —NR14R15, and —NR14R15 are in position 4 of said aryl;
R14 and R15, which may be identical or different, represent an atom or group chosen from:
a hydrogen atom;
a linear or branched C1-C6 alkyl radical which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino, (C1-C6)alkylimidazole, mono/di/tri(C1-C6)alkylammonium, An−, (C1-C6)alkylimidazolium An−, (C1-C6)alkylpyridinium An−; (C1-C6)alkylpiperidinium, An−; or else R14 and R15 form, together with the nitrogen to which they are attached, a cationic or non-cationic 4- to 7-membered heterocycle which may also contain one or more heteroatoms such as nitrogen, oxygen and/or sulfur, said heterocycle optionally being substituted with one or more radicals, which may be identical or different, chosen from hydroxyl, amino, (di)(C1-C6)alkylamino, C1-C6 alkoxy, mono/di/tri(C1-C6)alkylammonium, An−; (C1-C6)alkylimidazolium, An−; (C1-C6)alkylpyridinium, An−; or C1-C6 alkyl;
R′14 represents an atom or group chosen from:
hydrogen;
linear or branched C1-C6 alkyl which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyl, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino, (C1-C6)alkylimidazole, mono/di/tri(C1-C6)alkylammonium An−, (C1-C6)alkylimidazolium An−, (C1-C6)alkylpyridinium An−, (C1-C6)alkylpiperidinium An−.

### Claim 25 (depends on 20)

The compound of claim 20, wherein X represents a pyrazolopyridine group of formula (III) with
R9 representing:
a radical —NR′6R′7 with R′6 and R′7, which form, together with the nitrogen atom to which they are attached, a saturated, optionally substituted, optionally cationic, preferably catonic, 5- to 8-membered heterocycle, or else R′6 and R′7, which may be identical or different, represent:
a hydrogen atom;
a C1-C10 alkyl radical optionally substituted with one or more groups chosen from i) hydroxyl, ii) optionally substituted, 5- to 8-membered, cationic or non-cationic, saturated, unsaturated or aromatic (hetero)cycle, iii) —N(R′)R″, iv) —N+R′R″R′″ with R′, R″ and R″ each independently representing a C1-C6 alkyl group;
or
a radical —OR′6 with R′6 representing a C1-C10 alkyl radical optionally interrupted with one or more non-adjacent heteroatoms, and/or optionally substituted with one or more groups chosen from i) hydroxyl, ii) optionally substituted, 5- to 8-membered, cationic or non-cationic, saturated, unsaturated or aromatic (hetero)cycle, iii) —N(R′)R″, iv) —N+R′R″R′″ with R′, R″ and R′″ each independently representing a C1-C6 alkyl group;
in particular, R9 represents —OR′6 with R′6 representing a (poly)hydroxy(C1-C6 alkyl), preferably hydroxy(C1-C6 alkyl), group;
R10, R11, R12 and R13, which may be identical or different, represent an atom or group chosen from:
hydrogen;
halogen;
linear or branched C1-C6 alkyl which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino;
linear or branched C1-C6 alkoxy which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino; preferably, R10, R11, R12, and R13 represent a hydrogen atom.

### Claim 26 (depends on 20)

The compound of claim 20, wherein:
Z1 represents an oxygen atom or a group —N(R6)—, preferably Z1 represents an oxygen atom;
R2, R3, R4 and R5, which may be identical or different, represent an atom or group chosen from:
hydrogen;
halogen such as fluorine or chlorine;
linear or branched C1-C6 alkyl which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, mono(C1-C6)alkylamino or di(C1-C6)alkylamino; or
linear or branched C1-C6 alkoxy which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, mono(C1-C6)alkylamino or di(C1-C6)alkylamino;
R1 and R6, and/or R′6 and R′7, which may be identical or different, represent an atom or group chosen from:
a hydrogen atom;
a linear or branched C1-C6 alkyl radical which may be substituted with one or more radicals, which may be identical or different, chosen from a) hydroxyls; b) amino; c) (C1-C6)alkylamino; d) di(C1-C6)alkylamino; e) (C1-C6)alkylimidazolyl; f) mono/di/tri(C1-C6)alkylammonium, An−; g) (C1-C6)alkylimidazolium, An−; (C1-C6)alkylpyridinium, An−; i) (C1-C6)alkylpiperidinium, An−; j) (di)(C1-C6)alkylpiperazinium, An−; k) morpholino and l) (C1-C6)alkylmorpholinium;
X represents a radical of formula (II′) or of formula (III):
in which formulae (II′) and (III):
corresponds to the point of anchorage of the group (II) or (III) to the rest of the molecule;
n represents an integer between 0 and 4; when n is greater than or equal to 2, then the radicals R′8 may be identical or different;
R′8 represents an atom or group chosen from:
1) halogen such as fluorine or chlorine; 2) C1-C6, preferably C1-C4, alkyl, optionally substituted with one or more radicals chosen from the radicals i) hydroxyl, ii) C1-C2 alkoxy, iii) (poly)hydroxy(C2-C4)alkoxy, iv) acylamino, v) amino substituted with one or two identical or different C1-C4 alkyl radicals, optionally bearing at least one hydroxyl group, or the two radicals being able to form, with the nitrogen atom to which they are attached, a saturated or unsaturated heterocycle comprising from 5 to 7 members, preferably 5 or 6 members, optionally comprising another heteroatom identical to or different than nitrogen, vi) halogen; vii) cationic or non-cationic heterocycle, such as C1-C6 alkylimidazolium An−, C1-C6 alkylpyridinium An−, C1-C6 alkylpiperidinium An−; viii) C1-C6 mono/di/trialkylammonium; 3) hydroxyl; 4) C1-C6 alkoxy optionally substituted with one or more identical or different radicals chosen from i) hydroxyl; ii) amino, iii) C1-C6 mono- or dialkylamino; iv) (C1-C6)alkylimidazole; v) mono/di/tri(C1-C6)alkylammonium; vi) (C1-C6)alkylimidazolium An−; vii) (C1-C6)alkylpyridinium An−; viii) (C1-C6)alkylpiperidinium An−; 5) C1-C6 alkoxycarbonyl; 6) C1-C6 alkylcarbonyloxy; 7) (poly)hydroxy(C2-C4)alkoxy; 8) amino; 9) 5- or 6-membered heterocycloalkyl; 10) optionally cationic 5- or 6-membered heteroaryl, preferentially imidazolium, optionally substituted with a C1-C4 alkyl radical, preferentially methyl; 11) amino substituted with one or two identical or different C1-C6 alkyl radicals optionally bearing at least i) hydroxyl, ii) amino optionally substituted with one or two C1-C3 alkyl radicals, said alkyl radicals possibly forming, with the nitrogen atom to which they are attached, a saturated or unsaturated heterocycle comprising from 5 to 7 members, optionally comprising at least one other heteroatom different than or identical to nitrogen, iii) quaternary ammonium —N+R′R″R′″, M− for which R′, R″ and R′″, which may be identical or different, represent a hydrogen atom or a C1-C4 alkyl group; and M− represents an anionic counterion, in particular a halide, iv) optionally cationic 5- or 6-membered heteroaryl, preferentially imidazolium, optionally substituted with a C1-C4 alkyl radical, preferentially methyl; 12) quaternary ammonium —N+R′R″R′″, M− for which R′, R″, R′″ and M− are as defined previously; 13) acylamino (—N(R)—C(O)—R′) in which the radical R is a hydrogen atom or a C1-C4 alkyl radical optionally bearing at least one hydroxyl group and the radical R′ is a C1-C2 alkyl radical; 14) carbamoyl ((R)2N—C(O)—) in which the radicals R, which may be identical or different, represent a hydrogen atom or a C1-C4 alkyl radical optionally bearing at least one hydroxyl group; 15) alkylsulfonylamino (R′S(O)2—N(R)—) in which the radical R represents a hydrogen atom or a C1-C4 alkyl radical optionally bearing at least one hydroxyl group and the radical R′ represents a C1-C4 alkyl radical or a phenyl radical; 16) aminosulfonyl ((R)2N—S(O)2—) in which the radicals R, which may be identical or different, represent a hydrogen atom or a C1-C4 alkyl radical optionally bearing at least one hydroxyl group; 17) carboxyl in acid or salified form (preferably salified with an alkali metal or a substituted or unsubstituted ammonium); 18) cyano; 19) nitro; 20) polyhaloalkyl, preferentially trifluoromethyl; 21) carboxyl; 22) phenylcarbonyloxy optionally substituted with one or more hydroxyl groups; 23) phenyloxycarbonyl optionally substituted with one or more hydroxyl groups; 24) phenyl optionally substituted with one or more hydroxyl or alkoxy groups; and 25) phenoxy;
or else, when n is greater than or equal to 2, two contiguous radicals R′8 form, together with the carbon atoms which bear them, an optionally substituted (hetero)cycle;
R8 represents an atom or group chosen from:
hydrogen;
halogen;
—OR′14;
—NR14R15;
C1-C6 alkyl optionally substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, C1-C6 monoalkylamino or dialkylamino, halogen, C1-C6 alkylimidazole, C1-C6 trialkylammonium An−, C1-C6 alkylimidazolium An−, C1-C6 alkylpyridinium alkylpiperidinium An−;
carboxyl (—CO2H);
carboxamide (—CO2NH2);
R9 represents
a radical —OR′6; or
a radical —NR′6R′7;
R10, R11, R12 and R13, which may be identical or different, represent an atom or group chosen from:
hydrogen;
halogen;
linear or branched C1-C6 alkyl which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino; or
linear or branched C1-C6 alkoxy which may be substituted with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino;
R14 and R15, which may be identical or different, represent an atom or group chosen from:
a hydrogen atom;
a linear or branched C1-C6 alkyl radical optionally substituted in particular with one or more radicals, which may be identical or different, chosen from hydroxyls, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino, (C1-C6)alkylimidazole, mono/di/tri(C1-C6)alkylammonium, An−; (C1-C6)alkylimidazolium An−; (C1-C6)alkylpyridinium An−; (C1-C6)alkylpiperidinium, An−; or else R14 and R15 form, together with the nitrogen to which they are attached, a cationic or non-cationic 4- to 7-membered heterocycle which may also contain one or more heteroatoms such as nitrogen, oxygen and/or sulfur, said heterocycle possibly being substituted with one or more radicals, which may be identical or different, chosen from hydroxyl, amino, (di)(C1-C6)alkylamino, C1-C6 alkoxy, mono/di/tri(C1-C6)alkylammonium, An−; (C1-C6)alkylimidazolium, An−; (C1-C6)alkylpyridinium, An−; or C1-C6alkyl;
R′14 represents an atom or group chosen from:
hydrogen;
linear or branched C1-C6 alkyl optionally substituted in particular with one or more radicals, which may be identical or different, chosen from hydroxyl, amino, (C1-C6)alkylamino or di(C1-C6)alkylamino, (C1-C6)alkylimidazole, mono/di/tri(C1-C6)alkylammonium, An−, (C1-C6)alkylimidazolium An−, (C1-C6)alkylpyridinium An−, (C1-C6)alkylpiperidinium An−;
it being understood that:
when the compounds of formula (I) are cationic, then their electro-neutrality is provided by one or more cosmetically acceptable anionic counterion anions, which may be identical or different; and
when Y1 represents NH and Y2 represents a CH group, then X represents a radical (II) or (II′).

### Claim 27 (depends on 20)

The compound of claim 20, wherein X represents an aryl group of formula (II) or (II′) with R8 representing a radical —NR14R15; wherein R14 represents an atom or group chosen from i) hydrogen, and ii) (C1-C4)alkyl optionally substituted with one or more hydroxyl groups, and R15 represents an atom or group chosen from i) hydrogen, and ii) (C1-C6)alkyl optionally substituted with one or more hydroxyl groups, or a heterocycle, which is preferably cationic, such as (C1-C4)alkylimidazolium, An−.

### Claim 28 (depends on 20)

The compound of claim 20, wherein Z1 represents a radical —N(R6)— and X represents a radical (III) with R9 representing a group —N(R′6)—R′7 in which R1 and R6 and/or R′6 and R′7 form, together with the nitrogen atom which bears them, a cationic or non-cationic heterocycle chosen from piperazinyl, piperazinium, imidazolyl, pyrrolidinyl, pyridinyl, morpholinyl, morpholinium, piperidinyl, piperidinium.

### Claim 29 (depends on 20)

The compound of claim 20, wherein Z1 represents a radical —N(R6)— and X represents a radical (II) or (II′) with R1 and R6 representing a cationic or non-cationic heterocycle.

### Claim 30 (depends on 20)

The compound of claim 20, wherein the radicals R1, R6 and/or R′6 is (are) chosen from a hydrogen atom, a C1-C6 alkyl radical or a C1-C6 alkyl radical substituted with one or more hydroxyl groups.

### Claim 31 (depends on 20)

The compound of claim 20, wherein the azomethine dyes comprise two symmetrical pyrazolopyridine units of formulae (I′) below, and also the leuco forms, optical isomers, geometrical isomers and tautomers thereof, the acid or base addition salts thereof and the solvates thereof such as hydrates:
in which formula (I′):
Z″1 is chosen from an oxygen atom or a group —N(R″6)—;
when Z″1 represents —N(R″6)— then R″1 and R″6 may form, together with the nitrogen atom to which they are attached, a cationic or non-cationic, saturated, optionally unsaturated, heterocycle comprising 5 or 6 members, optionally substituted preferably with one or more (C1-C4)alkyl groups such as piperazinium, piperidinium or morpholinium optionally substituted with a (C1-C4)alkyl group;
R″1 represents a C1-C6 alkyl radical, optionally interrupted with one or more non-adjacent oxygen atoms, and/or optionally substituted with:
a hydroxyl radical,
a di(C1-C4)alkylamino radical,
a heterocycle optionally substituted with one or more C1-C4 alkyl and/or hydroxyl radicals and chosen from pyrrolidine, piperidine, morpholine, piperazine and imidazole;
R″6 represents:
a hydrogen atom,
a C1-C10 alkyl radical optionally substituted with a hydroxyl radical;
R″2, R″3, R″4 and R″5 each independently represent:
a hydrogen atom,
a C1-C4 alkyl radical.

### Claim 32 (depends on 20)

The compound of claim 20, wherein said compound is chosen from:
and also the organic or mineral acid or base addition salts thereof, the leuco forms thereof, the geometrical isomers thereof, the tautomers thereof, the solvates thereof, and the hydrates thereof, with An−, which may be identical or different, representing an anionic counterion.

### Claim 33 (depends on 20)

A cosmetic composition comprising at least one compound of claim 20.

### Claim 34

A method for dying keratin fibers, comprising applying to keratin fibers a compound chosen from azomethine dyes comprising at least one pyrazolopyridine unit of formulae (I), a leuco form, an optical isomer, a geometrical isomer, a tautomers thereof, an organic or mineral acid or base addition salt thereof, a solvate thereof, or a hydrate thereof:
in which formula (I):
Y1 and Y2, which may be identical or different, represent a nitrogen atom or a group C(R) with R representing a hydrogen atom or a (C1-C6)alkyl group;
Z1 represents an oxygen atom or a group —N(R6)—; when Z1 represents —N(R6)—, then R1 and R6 optionally form, together with the nitrogen atom to which they are attached, an optionally substituted, optionally cationic, 5- to 8-membered, saturated, unsaturated or aromatic heterocycle;
R1 and R6, which may be identical or different, represent:
a hydrogen atom;
a C1-C10 alkyl radical optionally interrupted with one or more non-adjacent heteroatoms, and/or optionally substituted;
an optionally substituted, 5- to 8-membered, cationic or non-cationic, saturated, unsaturated or aromatic (hetero)cyclic radical;
in particular R1 represents a (poly)hydroxy(C1-C6 alkyl) group;
R2, R3, R4, and R5, which may be identical or different, each independently represent:
a hydrogen atom;
an optionally substituted C1-C6 alkyl radical;
a group chosen from —NH2, —N(H)R10, —N(R11)R12, OH and/or —OR9, with R9 and R10 representing an optionally substituted, linear or branched C1-C6 alkyl, R11 and R12, which may be identical or different, representing an optionally substituted, linear or branched C1-C6 alkyl, it being possible for R11 and R12 to form, together with the nitrogen atom to which they are attached, a saturated, unsaturated or aromatic 5- to 8-membered heterocycle optionally containing one or more other heteroatoms or groups chosen from N, O, S, S(O)2 and C(O), the heterocycle being optionally substituted;
a halide and/or
R2, R3, R4, and R5 form, in pairs, with adjacent radicals, an optionally substituted, saturated or unsaturated (hetero)cycle;
X represents an optionally substituted aryl or optionally substituted heteroaryl radical;
wherein
when the compounds of formula (I) are cationic, then their electro-neutrality is provided by one or more cosmetically acceptable anions which may be identical or different; and
when Y1 represents NH and Y2 represents a CH group, then X represents a group other than a pyrazolo[1,5-a]pyridin-3-yl group which is optionally substituted.

### Claim 35 (depends on 20)

A process for preparing the compounds of claim 20, wherein formulae (I) is symmetrical, comprising:
starting from reagent A2 of 3,4-diamino type:
reacting at least two molar equivalents of pyrazolo[1,5-a]pyridine compound A1 comprising an amino group in position 3 with a reagent A2 which is free in position 6 of the aromatic ring and comprising in position 2 a radical Y which is either a hydrogen atom or an electrofugal group, then
maintaining the reaction medium under stirring for a time of between 5 minutes and 48 hours; and then
optionally purifying reaction products (I-A);
wherein in formulae A1, A2 and (I-A), the radicals R1, Z1, R2, R3, R4, R5, Y1 and Y2 are as defined previously and that, when Y1 represents NH then Y2 cannot represent a CH group and Y represents a hydrogen atom or an electrofugal atom or group, preferably an electrofugal atom or group, such as halogen, (poly)halo(C1-C6 alkoxy), or (poly)(halo)(C1-C6 alkyl)-SO3—.

### Claim 36 (depends on 20)

A process for preparing the compounds of claim 20, wherein formulae (I) is symmetrical, comprising:
starting from reagent A4 of 3,4-dinitro type:
reacting at least two molar equivalents of pyrazolo[1,5-a]pyridine compound A1 comprising an amino group in position 3 with a reagent A4 comprising in position 2 and 6 of the aromatic ring an electrofugal atom or group; then
maintaining the reaction medium under stirring for a time of between 5 minutes and 48 hours; then
optionally purifying the reaction product A6;
reducing A5
optionally purifying compound 1;
wherein R1, Z1, R2, R3, R4, R5, X, Y, Y1 and Y2 are as defined previously, and Y′ and Y″, which may be identical or different, represent an electrofugal atom or group, such as halogen, (poly)halo(C1-C6 alkoxy) or (poly)(halo)(C1-C6 alkyl)-SO3—; and that, when Y1 represents NH then Y2 does not represent a CH group; preferably, Y1 and Y2 represent a group C(R) with R representing a hydrogen atom or a (C1-C6)alkyl group.

### Claim 37 (depends on 20)

A process for preparing compounds of claim 20, wherein formulae (I) is symmetrical or dissymmetrical, comprising:
starting from reagent A2 of 3,4-diamino type:
reacting one molar equivalent of pyrazolo[1,5-a]pyridine compound A1 comprising an amino group in position 3 with a reagent A2 as defined previously; then
maintaining the reaction medium under stirring for a time of between 5 minutes and 48 hours, and then
optionally purifying the reaction product A3;
reacting compound A3 with one molar equivalent of a reagent bearing a (hetero)aryl group comprising a primary amine X—NH2 under the same conditions as steps 1) and 2),
optionally purifying a compound of formula (I);
wherein R1, Z1, R2, R3, R4, R5, X, Y, Y1 and Y2 are as defined previously, Y′ and Y″ represent an atom or group and that, when Y1 represents NH and Y2 represents a CH group, then X represents a group other than a pyrazolo[1,5-a]pyridin-3-yl group which is optionally substituted;

### Claim 38 (depends on 20)

A process for preparing compounds of claim 20, wherein formulae (I) is symmetrical or dissymmetrical, comprising:
starting from reagent A4 of 3,4-dinitro type:
reacting one molar equivalent of pyrazolo[1,5-a]pyridine compound A1 comprising an amino group in position 3 with a reagent A4 comprising in position 2 and 6 of the aromatic ring an electrofugal atom or group; then
maintaining the reaction medium under stirring for a time of between 5 minutes and 48 hours, and then
optionally purifying the reaction product A5; then
reacting compound A5 with one molar equivalent of a reagent bearing a (hetero)aryl group comprising a primary amine X—NH2 in a polar aprotic heteroaromatic solvent such as N-methylpyrrolidine; then
optionally reducing A′6 to give a compound of formula (I);
wherein R1, Z1, R2, R3, R4, R5, X, Y, Y1 and Y2 are as defined previously, and Y′ and Y″, which may be identical or different, represent an electrofugal atom or group, such as halogen, (poly)halo(C1-C6 alkoxy) or (poly)(halo)(C1-C6 alkyl)-SO3—;
and wherein Y1 represents NH and Y2 represents a CH group, then X represents a group other than a pyrazolo[1,5-a]pyridin-3-yl group which is optionally substituted.

### Claim 39 (depends on 20)

A multi-compartment device or kit, comprising, in at least one of the compartments, the compound of claim 20.
